Fund Holdings — Birchview Capital, LP

Total Portfolio Value:
$108.19M
Total Bought:
$4.92M
Total Sold:
$21.89M
Net Transaction:
-$16.96M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Bristol-Myers Squibb Company(BMY)703,606688,218-15,388$38.16M$28.58M26.42%-$9.57M
Biodesix, Inc.(BDSX)5,348,2735,696,113+347,840$7.63M$8.70M8.04%+$1.07M
Elutia Inc.(ELUT)1,655,1841,551,655-103,529$5.21M$7.70M7.11%+$2.48M
Neurocrine Biosciences, Inc.(NBIX)77,24042,240-35,000$10.65M$5.82M5.37%-$4.84M
Silk Road Medical Inc158,094158,0940$2.90M$4.27M3.95%+$1.38M
Prothena Corp PlcSHS
SHS
169,574203,574+34,000$4.20M$4.20M3.88%+$1.4K
Acadia Pharmaceuticals Inc250,400250,4000$4.63M$4.07M3.76%-$560.9K
Ovintiv Inc.(OVV)84,20074,200-10,000$4.37M$3.48M3.21%-$892.2K
United Therapeutics Corporation(UTHR)11,00010,000-1,000$2.53M$3.19M2.94%+$658.6K
Harrow, Inc.(HROW)150,000150,0000$1.98M$3.13M2.90%+$1.15M
Stoke Therapeutics, Inc.(STOK)210,000210,0000$2.83M$2.84M2.62%+$2.1K
Phreesia, Inc.(PHR)114,700114,7000$2.74M$2.43M2.25%-$313.1K
Corcept Therapeutics Incorporated(CORT)50,00074,000+24,000$1.26M$2.40M2.22%+$1.14M
Quidelortho Corp65,20367,619+2,416$3.13M$2.25M2.08%-$879.5K
Masimo Corp15,28015,2800$2.24M$1.92M1.78%-$319.5K
Foghorn Therapeutics Inc.(FHTX)320,930320,9300$2.15M$1.85M1.71%-$308.1K
Equitrans Midstream Corporatio133,050133,0500$1.66M$1.73M1.60%+$65.2K
Protagonist Therapeutics Inc48,00048,0000$1.39M$1.66M1.54%+$274.6K
Axogen, Inc.(AXGN)173,000197,000+24,000$1.40M$1.43M1.32%+$30.2K
DocGo Inc.(DCGO)460,000460,0000$1.86M$1.42M1.31%-$437.0K
Alkermes plcSHS(ALKS)50,00050,0000$1.35M$1.21M1.11%-$148.5K
Travere Therapeutics, Inc.(TVTX)122,000122,0000$940.6K$1.00M0.93%+$62.2K
Alphatec Holdings, Inc.(ATEC)88,00088,0000$1.21M$919.6K0.85%-$293.9K
Castle Biosciences, Inc.(CSTL)14,00034,000+20,000$310.1K$740.2K0.68%+$430.1K
Exxon Mobil Corp05,849+5,849$0$673.3K0.62%+$673.3K
Progyny Inc22,00022,0000$839.3K$629.4K0.58%-$209.9K
10x Genomics, Inc.CL A(TXG)30,00030,0000$1.13M$583.5K0.54%-$542.4K
Kiniksa Pharmaceuticals Ltd30,00030,0000$591.9K$560.1K0.52%-$31.8K
Kalvista Pharmaceuticals Inc46,00046,0000$545.6K$541.9K0.50%-$3.7K
Cytokinetics, Incorporated(CYTK)10,00010,0000$701.1K$541.8K0.50%-$159.3K
Apellis Pharmaceuticals Inc
COM
18,00014,000-4,000$1.06M$537.0K0.50%-$521.0K
Halozyme Therapeutics, Inc.(HALO)10,00010,0000$406.8K$523.6K0.48%+$116.8K
Coherus Oncology, Inc.(CHRS)270,000270,0000$645.3K$467.1K0.43%-$178.2K
Karyopharm Therapeutics Inc.(KPTI)469,832469,8320$709.4K$407.6K0.38%-$301.8K
Arvinas, Inc.(ARVN)15,00015,0000$619.2K$399.3K0.37%-$219.9K
Sarepta Therapeutics, Inc.(SRPT)2,5002,5000$323.6K$395.0K0.37%+$71.3K
Xenon Pharmaceuticals Inc.(XENE)10,00010,0000$430.5K$389.9K0.36%-$40.6K
Accelerate Diagnostics Inc325,239325,2390$322.0K$380.5K0.35%+$58.5K
Springworks Therapeutics Inc10,00010,0000$492.2K$376.7K0.35%-$115.5K
Cullinan Therapeutics, Inc.(CGEM)25,11420,000-5,114$427.9K$348.8K0.32%-$79.1K
NovoCure Limited(NVCR)020,000+20,000$0$342.6K0.32%+$342.6K
Axsome Therapeutics, Inc.(AXSM)4,0004,0000$319.2K$322.0K0.30%+$2.8K
Keros Therapeutics, Inc.(KROS)7,0007,0000$463.4K$319.9K0.30%-$143.5K
Bluebird Bio Inc321,200311,200-10,000$411.1K$306.3K0.28%-$104.9K
Amicus Therapeutics Inc
COM
28,00028,0000$329.8K$277.8K0.26%-$52.1K
Biohaven Pharmaceutical Holding Co Ltd7,3657,3650$402.8K$255.6K0.24%-$147.2K
BioCryst Pharmaceuticals, Inc.(BCRX)20,00040,000+20,000$101.6K$247.2K0.23%+$145.6K
Xencor, Inc.(XNCR)12,30012,3000$272.2K$232.8K0.22%-$39.4K
Wave Life Sciences, Inc.SHS(WVE)40,00040,0000$246.8K$199.6K0.18%-$47.2K
G1 Therapeutics Inc80,00080,0000$345.6K$182.4K0.17%-$163.2K
Inhibrx Biosciences, Inc.(INBX)012,110+12,110$0$170.6K0.16%+$170.6K
Gossamer Bio, Inc.(GOSS)138,176138,1760$163.0K$124.5K0.12%-$38.6K
Liquidia Corporation(LQDA)10,00010,0000$147.5K$120.0K0.11%-$27.5K
InflaRx N.V.(IFRX)50,00050,0000$77.0K$87.0K0.08%+$10.0K
Cabaletta Bio, Inc.(CABA)10,00010,0000$170.6K$74.8K0.07%-$95.8K
2seventy Bio Inc19,83317,833-2,000$106.1K$68.7K0.06%-$37.5K
Ventyx Biosciences Inc28,80028,8000$158.4K$66.5K0.06%-$91.9K
Zentalis Pharmaceuticals, Inc.(ZNTL)16,00016,0000$252.2K$65.4K0.06%-$186.7K
Outset Medical, Inc.(OM)010,000+10,000$0$38.5K0.04%+$38.5K
CERo Therapeutics Holdings, Inc.CL A(CERO)12,97212,9720$39.8K$3.9K0.00%-$35.9K
Inhibrx Inc48,4480-48,448$1.69M$0—-$1.69M
Pioneer Natural Resources Co3,8000-3,800$997.5K$0—-$997.5K
Yield10 Bioscience Inc18,7500-18,750$7.1K$0—-$7.1K
Page 1 of 1
Birchview Capital, LP — 13F Holdings — Q2 2024 | TickerTrail